700 related articles for article (PubMed ID: 18668574)
1. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM
Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574
[TBL] [Abstract][Full Text] [Related]
2. Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases.
Shen Y; Chen XW; Sun CY; Dai M; Yan YC; Yang CD
Lupus; 2010 Sep; 19(10):1195-203. PubMed ID: 20504833
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.
Kim MK; Maeng YI; Lee SJ; Lee IH; Bae J; Kang YN; Park BT; Park KK
Int J Clin Exp Pathol; 2013; 6(10):2157-67. PubMed ID: 24133594
[TBL] [Abstract][Full Text] [Related]
4. Glomerular c4d staining can be an indicator of disease activity in lupus nephritis.
Sahin OZ; Gurses S; Taslı F; Yavas H; Ersoy R; Uzum A; Cirit M
Ren Fail; 2013; 35(2):222-5. PubMed ID: 23176021
[TBL] [Abstract][Full Text] [Related]
5. Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: a pilot study.
Batal I; Liang K; Bastacky S; Kiss LP; McHale T; Wilson NL; Paul B; Lertratanakul A; Ahearn JM; Manzi SM; Kao AH
Lupus; 2012 Jan; 21(1):13-26. PubMed ID: 21959138
[TBL] [Abstract][Full Text] [Related]
6. Incidence and importance of c4d deposition in renal allograft dysfunction.
Demirci C; Sen S; Sezak M; Sarsik B; Hoşcoşkun C; Töz H
Transplant Proc; 2008; 40(1):174-7. PubMed ID: 18261578
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
8. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
[TBL] [Abstract][Full Text] [Related]
9. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
[TBL] [Abstract][Full Text] [Related]
10. The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients.
Ding Y; Yu X; Wu L; Tan Y; Qu Z; Yu F
Front Immunol; 2021; 12():654652. PubMed ID: 34276649
[TBL] [Abstract][Full Text] [Related]
11. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.
Liu CC; Manzi S; Kao AH; Navratil JS; Ruffing MJ; Ahearn JM
Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588
[TBL] [Abstract][Full Text] [Related]
12. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
15. Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis.
Kang EH; Moon KC; Lee EY; Lee YJ; Lee EB; Ahn C; Song YW
Lupus; 2009 Jan; 18(1):22-8. PubMed ID: 19074165
[TBL] [Abstract][Full Text] [Related]
16. Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.
Li SJ; Liu ZH; Zen CH; Wang QW; Wang Y; Li LS
Lupus; 2007; 16(11):875-80. PubMed ID: 17971360
[TBL] [Abstract][Full Text] [Related]
17. Glomerular C4d deposition indicates in situ classic complement pathway activation, but is not a marker for lupus nephritis activity.
Kim SH; Jeong HJ
Yonsei Med J; 2003 Feb; 44(1):75-80. PubMed ID: 12619178
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
19. Renal biopsy findings predicting outcome in scleroderma renal crisis.
Batal I; Domsic RT; Shafer A; Medsger TA; Kiss LP; Randhawa P; Bastacky S
Hum Pathol; 2009 Mar; 40(3):332-40. PubMed ID: 18973923
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing C1q nephropathy from lupus nephritis.
Sharman A; Furness P; Feehally J
Nephrol Dial Transplant; 2004 Jun; 19(6):1420-6. PubMed ID: 15004260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
